Symposium success! CELEBRATE IN STYLE
Transcription
Symposium success! CELEBRATE IN STYLE
October 2015 THE TOPRA NEWSLETTER – KEEPING MEMBERS IN TOUCH In this issue... Autumn usually feels like the start of a new term to me and this year is no different: TOPRA welcomes seven new Fellows and announces the new Board of Directors who will take office from January 2016. Congratulations to them all! On the subject of congratulations, there is an exciting line-up of entries in this year’s Awards for Regulatory Excellence. Why not join in the celebrations and raise awareness of the amazing achievements of regulatory professionals throughout the global life science sector. You never know – in the future a TOPRA Award could be yours! Greer Deal Director, Global Regulatory Services Co-Editor, InTouch Symposium success! SARAH ROBERTS, TOPRA PRESIDENT I am delighted to have heard very positive feedback about the 12th TOPRA Annual Symposium in Berlin. A company meeting in the US meant that I was unable to attend, but social media posts confirm that a good time was had both at the conference and in Berlin! I would like to take the opportunity to thank the Symposium Working Party for organising a superb programme and great opportunities for networking. This is no mean feat and takes a huge amount of hard work both prior to and during the event itself. Thank you to all! For me personally, it was strange not to be preparing a session report or two for the Regulatory Rapporteur on the plane home, but I know the editorial panel were there in force and I look forward to reading the reports in the next issue. During the Annual Review Meeting held at the Symposium, Past-President Jonathan Trethowan described the progress we had made on the strategy set for TOPRA. This highlighted the progress on digital services, (including the new member engagement system and increase in e-learning resources), on partnerships we have forged and of course the establishment of a new ‘home’ for TOPRA in our offices in South Quay. The newly published Annual Report for 2014–15 includes a full update of everything we have achieved during the last year with the help of our members and volunteers, and includes a summary of the positive financial results for 2014. The Annual Report has been circulated to all members electronically: if you have not spotted it in your packed inbox please let the office know! I urge you to read it: it is one way in which the Board, which is answerable to you as members, can make sure you are fully informed of everything happening in your organisation. The results of the TOPRA Board Elections have now been announced (see page 2). I would like to congratulate our new Board members and thank all of the candidates who put themselves forward for election – and of course to everyone who voted. I very much look forward to working as part of the 2016 TOPRA Board under the leadership of Thomas Kühler. With only a few weeks until the Awards for Regulatory Excellence, now is the time to book your tickets (see below). I would personally like to wish all the shortlisted nominees every success and look forward to an evening of celebrating excellence within our profession. Finally, next week after 6 months of maternity leave, I return to work. I have been thinking about which, if any, of my new-found transferable skills may be relevant in the workplace. I have to admit I am struggling to position knowing the words to over 50 nursery rhymes into the mix – but you never know! On a more serious note, it has given me a new appreciation of the importance of the necessity of developing medicines for paediatric use, with all that entails. CELEBRATE IN STYLE Last chance to book your tickets for the Awards for Regulatory Excellence! This year’s glittering ceremony will take place at the Royal College of Obstetricians and Gynaecologists in Regent’s Park, London on 18 November. A record number of entries were received this year and the Shortlists have been announced – it is now your chance to join us in celebrating regulatory excellence! BOOK NOW – Visit www.topra.org/awards15 for details and to book your seat. INNOVATION FUTURES CHAMPIONS ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION A WARM WELCOME TO OUR NEW TOPRA FELLOWS Paul Cooper, Assentra Nicola Hardman, JensonR+ Vimal Patel, Reckitt Benckiser Davina Stevenson, Gilead Sciences We are thrilled to welcome seven new Fellows to our organisation this month: Paul Cooper, Nicola Hardman, Vimal Patel, Davina Stevenson, Nick Sykes, Eszter Teleki and Chris Walker Paul Cooper was introduced to regulatory affairs at the start of his career in industry in 1984, and since 2012 has continued through Assentra, his own independent consultancy company. He has been Chair of the TOPRA Veterinary SPIN group and the Veterinary Variations CRED training since 2013. Nicola Hardman has 17 years of pharmaceutical industry experience, with 15 of those gained continuously in the regulatory field. Nicola has worked as a regulatory consultant in JensonR+ since 2009, and has contributed articles on topics including biopharmaceutical manufacturing to the Regulatory Rapporteur. Vimal Patel has worked in regulatory affairs for 18 years, and is currently Head of Global Compliance Projects at Reckitt Benckiser. Since 2009 Vimal has made significant contribution to the TOPRA CRED CMC course, and as a member of the TOPRA Professionalism Committee has helped to develop the CPD programme. Davina Stevenson has worked in regulatory and pharmaceuticals for 16 years and is currently Associate Director Regulatory Affairs, Liver Disease at Gilead Sciences. She has been a member of the TOPRA Regulatory Rapporteur Editorial Board since 2010, and wrote The TOPRA Guide to Regulatory Intelligence (2012). Nick Sykes has been working in regulatory since joining SmithKline Beecham in 1992 as part of their Regulatory Intelligence team. He is currently a Senior Director at Pfizer, and Nick speaks regularly at the TOPRA Spring Introductory Course and the Annual Symposium. Eszter Teleki is a medical doctor by training, with 20 years of pharmaceutical and regulatory experience. She has spoken at a number of international meetings and conferences and was one of the co-founders of the Hungarian Regulatory Affairs Professional Society (HURAS). Chris Walker joined the regulatory profession in 1996 at Bio Products Laboratories (BPL), and has since been based at Amgen. He completed the TOPRA MSc in 2002, and has since spoken at the Introductory Course. Chris is an active member of a number of trade association committees. Nick Sykes, Pfizer Eszter Teleki, BristolMyers Squibb Chris Walker, Amgen Thank you for choosing our new Board members TOPRA announced the new Board of Directors at the Annual Review Meeting in Berlin on 13 October, appointed after a well-supported election process The successful candidate for President-Elect was Robert (Bob) Clay, Chief Regulatory Officer at Kinapse and Director of Highbury Regulatory Science. Along with Bob, four new Directors were appointed at the meeting and are all due to take office from January 2016. The new Directors will be Lena Björk (Director of Supervision, Medical Products Agency), Will Drury (Senior Business Associate, Cyton Biosciences), Aileen Fisher (VP Regulatory Affairs, Kinapse) and Sharon Gorman (Director EU Bob Clay Lena Björk Will Drury Aileen Fisher Sharon Gorman Regulatory Policy, Pfizer). TOPRA InTouch Newsletter – October 2015 TOPRA InTouch Newsletter – October 2015 12 TH TOPRA ANNUAL SYMPOSIUM Highlights from Berlin TOPRA’s Annual Symposium – a key event in the regulatory calendar – took place on TOPRA is pleased to announce the shortlisted nominees for the Awards for Regulatory Excellence, 12–14 October in Berlin, Germany. This year’s conference was held in conjunction with the Federal Institute following careful consideration of all entries by our prestigious panel of judges. This year’s for ceremony Drugs and will Medical Devices (BfArM) and the Federal Office of Consumer Protection and Food Safety (BVL). be held at the Royal College of Obstetrics and Gynaecology on 18 November 2015 1 2 3 4 5 1. Prof. Dr. med. Karl Broich, President of BfArM in Germany, opened this year’s Symposium by presenting the fourth TOPRA Annual Lecture on the subject of ‘Next Generation Sequencing’. 2.More than 400 delegates attended the three-day conference, held this year at the Maritim proArte Hotel in Berlin. 6 7 3.(L–R) TOPRA Executive Director Lynda Wight with Birka Lehmann, Head of Unit at BfArM, Karl Broich, President of BfArM and Christine Mayer-Nicolai, Senior Director, Head Europe Global Regulatory & Scientific Policy, Merck Serono. 4.Congratulations to Sandra NavarroCarrasco from Hibernia College, Ireland, who won first prize in the Student Poster Competition. 8 9 5. Celebrations were also in order for this year’s ‘TOP Team’, presented to Margareth Jorvid on behalf of TOPRA In Sweden. 6.A delighted Melanie Leivers, Working Party Member for the Veterinary Symposium, received the Distinguished Service Award for her valued contribution to TOPRA. 10 11 7/8. The Exhibition Hall was a hive of activity with almost 30 market-leading exhibitors in attendance spanning translation, recruitment, consultancy and more! 9/10.The German themed Symposium Networking Dinner was the perfect close to a busy first day of sessions, and delegates were treated to musical entertainment by the ‘Berlin Trio’. 11.TOPRA President-Elect Thomas Kühler looked to the future of TOPRA in the 2015 Annual Review Meeting. ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION TOPRA InTouch Newsletter – October 2015 Diamond BioPharm hits the big 10! This October, Diamond BioPharm celebrates 10 years of supporting the pharmaceutical and biotech industry. Company founder and TOPRA Fellow Maureen Graham reflects on the highlights of the last decade... In October 2005 the doors opened to Diamond BioPharm, a regulatory affairs consulting organisation. Making the decision to move away from the security of working for a pharmaceutical company and starting a business was scary, to say the least – but it had to be done! Before stepping out alone, I gained extensive regulatory and development experience across many product types and from major multi-nationals such as Amgen, Merck Sharp and Dohme, Ivax (now Teva) and Glaxo. I knew I wanted to continue to work with people around me and not on my own, so I started out in a serviced office with an administrative colleague. Over the 10 years, the organisation has grown and currently employs around 20 people across the UK and US. I cannot mention them all here, but they are a fabulous, strong team! Since the company was founded a number In-House Editor Rachel Cook Co-Editors Greer Deal, Ishbel MacDonald and Graeme Ladds Publisher Jenine Willis How to contact InTouch The Diamond BioPharm team celebrate their 10th anniversary this month, led by Company Director Maureen Graham (front row, 4th left). of challenges have presented themselves to the pharmaceutical and biotech industry. Diamond BioPharm has sought to overcome these for our clients in order to ensure regulatory challenges and changes are met with innovation and compliance. Our team is able to draw on a wealth of experience, and we continue to look to provide services that offer maximum value to our clients in the most efficient and cost-effective manner. The hard work of the Diamond team was recently reflected in them winning the Innovation Category in the TOPRA Awards for Regulatory Excellence in 2013. The hardest thing in starting a business was choosing the name – but, for my ex-Amgen colleagues, it had to feature Diamonds! NEWTOPRAMEMBERS TOPRA welcomes the following new members who joined recently Miss Claire Starr, Regulatory Operations Associate II, Gilead Sciences, Great Abington, UK* Ms Barbara Lachmann, Labelling Consulting, Hofheim, Germany* Mrs Priya Vasudeva, Regulatory Affairs Officer, London, UK Miss Sarah Laird, Regulatory Affairs Associate, Reckitt Benckiser, London, UK* Ms Ida Sophie Grew, Regulatory Affairs Professional, Novo Nordisk, Soeborg, Denmark Mr Viren Bhatia, Pharmacist, Tudor Pharmacy, Northampton, UK Mrs Abigail Matthews, Safety Reporting Specialist, Novella Clinical, Norwich, UK Dr Anne-Marie McNicol, Regulatory Specialist, Novella Clinical, Stevenage, UK Miss Adesola Alade, Regulatory Safety Associate, Novella Clinical, Hertfordshire, UK Dr April Marquick, Regulatory Affairs Associate, Novella Clinical, Hertfordshire, UK Mr Farhad Salam, Regulatory Affairs Associate, Novella Clinical, Hertfordshire, UK Miss Mariya Petkova, University of Aberdeen, UK (Student) Miss Anita Chiverton, Harborne, UK (Student) Miss Caroline Haegeman, London, UK (Student) Mr Mehraj Ahmed, Kings College London, St Ives, UK (Student) Miss Laura Maginley, Kings Langley, UK (Student) Mr Robbie McCann, Head of Quality & Reg Affairs, Tangerine Holdings, Preston, UK* Mr Bhagwant Ubhi, Senior Regulatory Affairs Manager, Pfizer Consumer Healthcare, Oakville, Canada* Miss Helene Deconinck, UCL School of Pharmacy, London, UK (Student) Mr Seth Cunningham, Wells, UK (Student) Mr Arnór Jonsson, Global Regulatory Affairs Associate, Ferring Pharmaceuticals, Copenhagen, Denmark* Mrs Keral Patel, Regulatory Affairs Officer, Merck Sharp & Dohme, Hoddesdon, UK* Ms Lilya Winterton, Pfizer Consumer Healthcare, Tadworth, UK Miss Sarah Robertson, Regulatory Affairs Specialist, Endo Ventures, Ballsbridge, Ireland Dr Ralf Herbold, Head of RA Emerging Markets Biosimilars, Boehringer Ingelheim Pharma, Frankfurt, Germany Mr Luke Cunlisse, University of Leeds, Wigan, UK (Student) Mr Daniel Lewis, University of Hertfordshire, Baldock, UK (Student) Dr Haven McCall, Vice President Regulatory Affairs, Megadyne Medical Products, Draper, US Dr Nonna Holpné Kozlova, Senior Regulatory Consultant, Reginfo, Pest, Hungary* Ms Marie-Claire GatineauChazal, Regulatory Operations Associate, EUSA Pharma, Lyon, France If you would like to contribute to the newsletter, or find out about deadlines, please contact Rachel Cook ([email protected]). Please address any articles and correspondence to: [email protected] or submit your contribution via www.topra.org/intouch Views expressed in InTouch are those of the contributors and not necessarily those of the editors or TOPRA. While every effort is made to ensure information is accurate, conditions may change and readers are advised to consult current official texts and/or to seek appropriate professional advice before taking any regulatory action. © 2015 The Organisation for Professionals in Regulatory Affairs TOPRA 6th Floor 3 Harbour Exchange South Quay London E14 9GE Tel:+44 (0) 20 7510 2560 Fax:+44 (0) 20 7537 2003 E-mail: [email protected] InTouch is free to TOPRA members. Annual membership of TOPRA is £190. TOPRA members can read or download InTouch online at www.topra.org Mrs Sonal Patil, Regulatory Affairs, Medreich, Feltham, UK* Ms Eduarda Batista, EU Strategist, Pfizer, Tadworth, UK* Mr Mark Roessel, Vice President, Concert Pharmaceuticals, Lexington, US Miss Katharine Miller, Lead Associate, Genpact Pharmalink, Maidenhead, UK Dr Fiona McMonagle, RA Executive, Wockhardt, Wrexham, UK* TOPRA is the registered trademark of the The Organisation for Professionals in Regulatory Affairs Ltd, registered community trademark number 003182961. The TOPRA logo is covered by the Community Design Registration Numbers EU Des Reg no. 000055553-0001 and 0002. *Registered Member ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION
Similar documents
Welcome to our new home AWARDS VENUE ANNOUNCED
out about deadlines, please contact Rachel Cook ([email protected]). Please address any articles and correspondence to: [email protected] or submit your contribution via www.topra.org/intouch Views ...
More information